110 related articles for article (PubMed ID: 38065906)
1. Efficacy and safety of CKD-495 in acute and chronic gastritis: A Phase III superiority clinical trial.
Seo SY; Lee ST; Kim SK; Chun HJ; Song GA; Lee DH; Kim JJ; Kim JI; Lee YC; Kim TN; Jee SR; Park SY; Kim JG; Park JJ; Kim SG; Park JM; Park JH; Park SJ; Lee OY
Medicine (Baltimore); 2023 Dec; 102(49):e35926. PubMed ID: 38065906
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Fexuprazan in Patients with Acute or Chronic Gastritis.
Kim GH; Choi MG; Kim JI; Lee ST; Chun HJ; Lee KL; Choi SC; Jang JY; Lee YC; Kim JG; Kim KB; Shim KN; Sohn CI; Kim SK; Kim SG; Jang JS; Kim N; Jung HY; Park H; Huh KC; Lee KJ; Hong SJ; Baek S; Han JJ; Lee OY
Gut Liver; 2023 Nov; 17(6):884-893. PubMed ID: 36789577
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Efficacy and Safety of DA-9601 versus Its New Formulation, DA-5204, in Patients with Gastritis: Phase III, Randomized, Double-Blind, Non-Inferiority Study.
Choi YJ; Lee DH; Choi MG; Lee SJ; Kim SK; Song GA; Rhee PL; Jung HY; Kang DH; Lee YC; Lee SH; Choi SC; Shim KN; Seol SY; Moon JS; Shin YW; Kim HS; Lee ST; Cho JW; Choi EK; Lee OY; Jang JS
J Korean Med Sci; 2017 Nov; 32(11):1807-1813. PubMed ID: 28960033
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study.
Kim GH; Lee HL; Joo MK; Park HJ; Jung SW; Lee OJ; Kim H; Chun HJ; Lee ST; Kim JW; Jeon HH; Chung IK; Kim HS; Lee DH; Kim KO; Lim YJ; Park SJ; Cho SJ; Kim BW; Ko KH; Jeon SW; Kim JG; Sung IK; Kim TN; Sung JK; Park JJ
Gut Liver; 2021 Nov; 15(6):841-850. PubMed ID: 33827990
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Efficacy and Safety of DW1903 in Patients with Gastritis: A Randomized, Double-Blind, Noninferiority, Multicenter, Phase 3 study.
Kim JH; Jung HY; Yoo IK; Park SY; Kim JG; Sung JK; Jang JS; Cheon GJ; Kim KO; Kim TO; Lee ST; Cho KB; Chun HJ; Park JJ; Park MI; Jang JY; Jeon SW; Cho JW; Kang DH; Kim GH; Kim JJ; Kim SG; Kim N; Lee YC; Hong SJ; Kim HS; Lee S; Lee SW
Gut Liver; 2024 Jan; 18(1):70-76. PubMed ID: 37309193
[TBL] [Abstract][Full Text] [Related]
6. Chinese herbal compound prescriptions combined with Chinese medicine powder based on traditional Chinese medicine syndrome differentiation for treatment of chronic atrophic gastritis with erosion: a multi-center, randomized, positive-controlled clinical trial.
Zhang T; Zhang B; Xu J; Ren S; Huang S; Shi Z; Guo S; Bian L; Wang P; Wang F; Cai Y; Tang X
Chin Med; 2022 Dec; 17(1):142. PubMed ID: 36550503
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effectiveness of geranylgeranylacetone with cimetidine in gastritis patients with dyspeptic symptoms and gastric lesions: a randomized, double-blind trial in Japan.
Sakamoto C; Ogoshi K; Saigenji K; Narisawa R; Nagura H; Mine T; Tada M; Umegaki E; Maekawa T; Maekawa R; Maeda K
Digestion; 2007; 75(4):215-24. PubMed ID: 17971666
[TBL] [Abstract][Full Text] [Related]
8. The safety and efficacy of Houtou Jianweiling tablet in patients with chronic non-atrophic gastritis: a double-blind, non-inferiority, randomized controlled trial.
Shah MR; Fatima S; Khan SN; Shafiullah ; Azam Z; Shaikh H; Majid S; Chengdong H; Daijun Z; Wang W
Front Pharmacol; 2024; 15():1293272. PubMed ID: 38440179
[No Abstract] [Full Text] [Related]
9. Therapeutic effects of cetraxate against acute gastritis and acute aggravation of chronic gastritis. Endoscopic investigation by the double-blind method.
Yamagata S; Miura K
Arzneimittelforschung; 1983; 33(8):1191-5. PubMed ID: 6357203
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of Chinese herbal medicine Qirui Weishu capsule in treating chronic non-atrophic gastritis: A multicentre, double-blind, randomized controlled clinical trial.
Chen HF; Gong Y; Huang Z; Zhao G; Chen ZM; Zen YM; Li HZ; Hu YL
J Ethnopharmacol; 2022 Aug; 294():115341. PubMed ID: 35551978
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of irsogladine maleate in nonsteroidal anti-inflammatory drug or aspirin-induced peptic ulcer and gastritis.
Shim KN; Kim JI; Kim N; Kim SG; Jo YJ; Hong SJ; Shin JE; Kim GH; Park KS; Choi SC; Kwon JG; Kim JH; Kim HJ; Kim JW
Korean J Intern Med; 2019 Sep; 34(5):1008-1021. PubMed ID: 29847892
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial.
Barnett AH; Mithal A; Manassie J; Jones R; Rattunde H; Woerle HJ; Broedl UC;
Lancet Diabetes Endocrinol; 2014 May; 2(5):369-84. PubMed ID: 24795251
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Elian Granules in treating chronic atrophic gastritis: study protocol for a randomized, double-blind, placebo-controlled, multicenter clinical trial.
Gu Z; Jia Q; Cong J; Cen R; Chen Y; Wu C; Gong B; Tang X; Ling J
Trials; 2022 May; 23(1):437. PubMed ID: 35610625
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
16. [Endoscopic and morphometric analysis of the reduction of acute inflammatory process in the gastric mucosa after therapy with Regasthym Gastro].
Baryshnikova NV; Uspenskiy YP; Fominykh YA; Petlenko SV; Zaplutanov VA; Apryatina VA; Krasnov AA
Ter Arkh; 2023 May; 95(4):322-326. PubMed ID: 38158980
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of valsartan in children aged 1-5 years with hypertension, with or without chronic kidney disease: a randomized, double-blind study followed by open-label phase.
Jankauskiene A; Drozdz D; Wasilewska A; de Paula-Bernardes R; Glazer R; Valentin M; Tan M; Chiang Y; Bapatla K
Curr Med Res Opin; 2021 Dec; 37(12):2113-2122. PubMed ID: 34543161
[TBL] [Abstract][Full Text] [Related]
18. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A
CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943
[TBL] [Abstract][Full Text] [Related]
19. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
[TBL] [Abstract][Full Text] [Related]
20. DA-9601 for erosive gastritis: results of a double-blind placebo-controlled phase III clinical trial.
Seol SY; Kim MH; Ryu JS; Choi MG; Shin DW; Ahn BO
World J Gastroenterol; 2004 Aug; 10(16):2379-82. PubMed ID: 15285023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
